317 related articles for article (PubMed ID: 1836011)
1. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
Kalli KR; Hsu PH; Bartow TJ; Ahearn JM; Matsumoto AK; Klickstein LB; Fearon DT
J Exp Med; 1991 Dec; 174(6):1451-60. PubMed ID: 1836011
[TBL] [Abstract][Full Text] [Related]
2. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
[TBL] [Abstract][Full Text] [Related]
3. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
Molina H; Kinoshita T; Webster CB; Holers VM
J Immunol; 1994 Jul; 153(2):789-95. PubMed ID: 8021513
[TBL] [Abstract][Full Text] [Related]
4. Binding of C3b and C4b by the CR1-like site in murine CR1.
Kalli KR; Fearon DT
J Immunol; 1994 Mar; 152(6):2899-903. PubMed ID: 8144890
[TBL] [Abstract][Full Text] [Related]
5. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
Wong WW; Farrell SA
J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
[TBL] [Abstract][Full Text] [Related]
6. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.
Kalli KR; Ahearn JM; Fearon DT
J Immunol; 1991 Jul; 147(2):590-4. PubMed ID: 1830068
[TBL] [Abstract][Full Text] [Related]
7. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.
Klickstein LB; Wong WW; Smith JA; Weis JH; Wilson JG; Fearon DT
J Exp Med; 1987 Apr; 165(4):1095-112. PubMed ID: 2951479
[TBL] [Abstract][Full Text] [Related]
8. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1).
Reilly BD; Makrides SC; Ford PJ; Marsh HC; Mold C
J Biol Chem; 1994 Mar; 269(10):7696-701. PubMed ID: 8125996
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
Carel JC; Myones BL; Frazier B; Holers VM
J Biol Chem; 1990 Jul; 265(21):12293-9. PubMed ID: 1695627
[TBL] [Abstract][Full Text] [Related]
11. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
Tuveson DA; Ahearn JM; Matsumoto AK; Fearon DT
J Exp Med; 1991 May; 173(5):1083-9. PubMed ID: 1708808
[TBL] [Abstract][Full Text] [Related]
12. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor.
Kinoshita T; Thyphronitis G; Tsokos GC; Finkelman FD; Hong K; Sakai H; Inoue K
Int Immunol; 1990; 2(7):651-9. PubMed ID: 1703784
[TBL] [Abstract][Full Text] [Related]
13. Co-operation between human CR1 (CD35) and CR2 (CD21) in internalization of their C3b and iC3b ligands by murine-transfected fibroblasts.
Grattone ML; Villiers CL; Villiers MB; Drouet C; Marche PN
Immunology; 1999 Sep; 98(1):152-7. PubMed ID: 10469246
[TBL] [Abstract][Full Text] [Related]
14. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.
Krych M; Hourcade D; Atkinson JP
Proc Natl Acad Sci U S A; 1991 May; 88(10):4353-7. PubMed ID: 1827918
[TBL] [Abstract][Full Text] [Related]
15. Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.
Lowell CA; Klickstein LB; Carter RH; Mitchell JA; Fearon DT; Ahearn JM
J Exp Med; 1989 Dec; 170(6):1931-46. PubMed ID: 2479703
[TBL] [Abstract][Full Text] [Related]
16. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD.
Tsokos GC; Thyphronitis G; Jack RM; Finkelman FD
J Immunol; 1988 Aug; 141(4):1261-6. PubMed ID: 2969399
[TBL] [Abstract][Full Text] [Related]
17. Genomic analysis reveals a duplication of eight rather than seven short consensus repeats in primate CR1 and CR1L: evidence for an additional set shared between CR1 and CR2.
McLure CA; Williamson JF; Stewart BJ; Keating PJ; Dawkins RL
Immunogenetics; 2004 Dec; 56(9):631-8. PubMed ID: 15526096
[TBL] [Abstract][Full Text] [Related]
18. Differential interaction of the C3b/C4b receptor and MHC class I with the cytoskeleton of human neutrophils.
Jack RM; Ezzell RM; Hartwig J; Fearon DT
J Immunol; 1986 Dec; 137(12):3996-4003. PubMed ID: 2946771
[TBL] [Abstract][Full Text] [Related]
19. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
Ahearn JM; Fearon DT
Adv Immunol; 1989; 46():183-219. PubMed ID: 2551147
[No Abstract] [Full Text] [Related]
20. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
